Yijun Chen
639 Longmian Avenue
Nanjing, 211198, China
Nanjing, 211198, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Biomimetic trident lipid anchoring enables stable neutrophil-based combination therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 25, 2025
Oxidative modification of G-quadruplex triggers CLIC4-associated mitochondrial dysfunction to promote glioblastoma progression.
Journal: Redox biology
Published: October 22, 2025
Non-genetically reprogrammed meta-neutrophils potentiate chemo-immunotherapy against lung metastatic triple-negative breast cancer.
Journal: Cell reports. Medicine
Published: September 16, 2025
Gene conversion-associated successive engineering of modular polyketide synthases.
Journal: Communications chemistry
Published: June 25, 2025
Pharmacokinetic and pharmacodynamic studies of injectable nocathiacin as a novel antibacterial agent.
Journal: npj antimicrobials and resistance
Published: April 16, 2025
Engineering a cytochrome P450 enzyme as a peroxygenase for selective hydroxylation of steroids.
Journal: Nature communications
Published: March 08, 2025
A broad-spectrum antibiotic targets multiple-drug-resistant bacteria with dual binding targets and no detectable resistance.
Journal: Nature communications
Published: February 07, 2025
The m6A reader IGF2BP1 contributes to the activation of hepatic stellate cells through facilitating TUBB4B mRNA stabilization.
Journal: Journal of gastroenterology and hepatology
Published: August 16, 2024
Adenosine deaminase is a risk factor for mortality after discharge in patients with acute myocardial infarction: Long-term clinical follow-up.
Journal: Heliyon
Published: February 20, 2024
Targeted degradation of oncogenic BCR-ABL by silencing the gene of NEDD8 E3 ligase RAPSYN.
Journal: Journal of nanobiotechnology
Published: January 02, 2024
The combination of tetracyclines effectively ameliorates liver fibrosis via inhibition of EphB1/2.
Journal: International immunopharmacology
Published: October 07, 2023
Last Updated: 09/26/2026